Allergan To Sell Lap-Band Franchise To Apollo For Up To $110 Million
This article was originally published in The Gray Sheet
Executive Summary
The firm announced Oct. 29 an agreement with Apollo Endosurgery to sell its obesity intervention business, including the Lap-Band adjustable band.
You may also be interested in...
Allergan Fortifies Defenses In Response To Valeant’s Hostile Bid
Allergan’s board adopted a so-called poison pill stockholder rights plan to hold off Valeant’s hostile takeover effort while it reviews the unsolicited offer.
News Briefs: Biomet IPO; Hep C Screening Coverage; Valve Guidelines
Biomet’s parent company filed an initial public offering registration statement for the firm March 7. CMS proposes national coverage for hepatitis C screening. ACC and AHA release new heart valve guidelines. More news.
News In Brief
Allergan Lap-Band unit on the block? DOJ investigates Abiomed Impella marketing. St. Jude Medical expands job cuts. More news briefs.